Our AI scores Nutriband Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Nutriband Inc. is a small-cap company with a market capitalization of $68M.
It ranks number 14 by market capitalization among the 26 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
For NTRB, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 8.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -16.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does.
Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, NTRB included.
Price
NTRB price chart and AI forecast
NTRB
Cross-section · 2026-11-06
How NTRB ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Valuation & Market
Metric
NTRB
Industry median
Rank
Market Cap
$68M
$78M
14/26
P/B Ratio
12.72x
2.48x
3/20
EPS
$-0.53
–
–
Book Value/Share
$0.44
–
–
Revenue/Share
$0.13
–
–
Profitability & Margins
Metric
NTRB
Industry median
Rank
ROE
-130.7%
-25.0%
14/19
ROA
-110.6%
-12.9%
18/19
ROIC
-130.8%
-4.9%
20/21
Gross Margin
33.1%
47.3%
15/19
Operating Margin
-435.6%
-7.6%
16/20
Net Margin
-430.4%
-14.3%
17/18
EBT Margin
-430.4%
-12.4%
16/20
Financial Health
Metric
NTRB
Industry median
Rank
Current Ratio
4.21x
2.55x
4/24
Quick Ratio
4.02x
1.66x
3/21
D/E Ratio
0.18x
0.77x
20/23
Financial Leverage
1.18x
1.77x
20/23
Interest Coverage
-182.7x
-4.4x
15/20
Working Capital
$3M
$71M
22/24
Cash Flow
Metric
NTRB
Industry median
Rank
Operating Cash Flow
-$4M
-$680K
16/24
Operational Efficiency
Metric
NTRB
Industry median
Rank
Asset Turnover
0.26x
0.64x
16/17
Receivables Turnover
68.6x
5.6x
2/16
Inventory Turnover
6.3x
2.1x
2/21
Fixed Assets Turnover
3.0x
5.1x
14/18
Days Sales Outstanding
5 days
66 days
15/16
Days Inventory
58 days
177 days
20/21
Income Statement
Metric
NTRB
Industry median
Rank
Total Revenue
$2M
$150M
17/18
Operating Income
-$7M
-$7M
13/24
Net Income
-$7M
-$7M
10/20
R&D Expense
$1M
$20M
18/21
SG&A Expense
$6M
$182M
20/21
Cost of Goods Sold
$1M
$79M
18/21
Dividend & Shareholder Information
Metric
NTRB
Industry median
Rank
Shares Outstanding
12M
–
–
Balance Sheet Highlights (USD millions)
Total Current Assets
$4M
60.7% of assets
Cash & Short-term Investments
$3M
54.4% of assets
Accounts Receivable
$20K
0.3% of assets
Inventory
$170K
2.7% of assets
Total Liabilities
$960K
15.3% of assets
Quarterly Financial Reports
NTRB quarterly financials and insider trading
Industry Peers · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Nutriband Inc. (NTRB) industry peers
Companies classified under the same SEC industry code as Nutriband Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 26 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Nutriband Inc. announced it has received a Notice of Allowance from the USPTO for its patent application regarding the Aversa™ abuse deterrent technology, which is designed to prevent the misuse and ...
More news available
Sign up free to read all 8 news articles and stay updated on market developments.
Our AI scores Nutriband Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Nutriband Inc. stock predictions?
For NTRB, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 8.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -16.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Nutriband Inc. forecasts updated?
Nutriband Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Nutriband Inc.'s industry peers?
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
AI analystLive data
Intratio Assistant
Ask anything
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.